| T0 | T1 | T2 |
---|
CRP (mg/dl) | 12.3 | 12 | 2.3 |
PCT (ng/ml) | 3.2 | 3 | 1 |
EAA | 0.71 | 0.6 | 0.5 |
FEVER (°C) | 40 | 38 | 36.5 |
SVR (dynes second/cm5) | 400 | 600 | 1200 |
CO | 2.1 | 3.0 | 5.2 |
MAP | 50 | 70 | 85 |
- T0: Before the beginning of IgM-enriched immunoglobulin preparation (Pentaglobin) and direct hemoperfusion therapy with polymyxin B immobilized fiber cartridges
- T1: 24 hours after the beginning of IgM-enriched immunoglobulin preparation (Pentaglobin) and direct hemoperfusion therapy with polymyxin B immobilized fiber cartridge
- T2: 72 hours after the beginning of IgM-enriched immunoglobulin preparation (Pentaglobin) and direct hemoperfusion therapy with polymyxin B immobilized fiber cartridge
- CO cardiac output, CRP C-reactive protein, EAA endotoxin activity assay, MAP mean arterial pressure, PCT procalcitonin, SVR systemic vascular resistance